Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol., 06 May 2022
Sec. Virology
This article is part of the Research Topic Emerging SARS-COV-2 Variants: Genomic Variations, Transmission, Pathogenesis, Clinical Impact and Interventions View all 65 articles

Epidemiological Characteristics of COVID-19 Outbreak in Yangzhou, China, 2021

\r\nYu-Dong Zhang&#x;Yu-Dong Zhang1†Ding Chen&#x;Ding Chen2†Lei Hu&#x;Lei Hu3†Liang ShenLiang Shen4Ren-Yuan WuRen-Yuan Wu5Fu-Ming CaoFu-Ming Cao6Jian-Qiang XuJian-Qiang Xu4Liang Wang*\r\nLiang Wang2*
  • 1The First Clinical Medical College of Xuzhou Medical University, Xuzhou, China
  • 2School of Medical Informatics and Engineering, Xuzhou, China
  • 3School of Mathematics, China University of Mining and Technology, Xuzhou, China
  • 4School of Management, Xuzhou Medical University, Xuzhou, China
  • 5School of Medical Imaging, Xuzhou Medical University, Xuzhou, China
  • 6The Second Clinical Medical College of Xuzhou Medical University, Xuzhou, China

Objective: Epidemiological characteristics of COVID-19 outbreak in Yangzhou city caused by the highly contagious Delta variant strain of SARS-CoV-2 virus were investigated in this retrospective descriptive study to provide prevention and control guidelines for outbreaks in the future.

Methods: All the epidemiological data used in this study were collected manually from the official website of the Yangzhou Municipal Health Committee from 28 July to 26 August 2021, and then were analyzed systematically and statistically in this study.

Results: A total of 570 COVID-19 cases were reported during the short-term outbreak in Yangzhou City. The ages of infected individuals ranged from 1 to 90 years with the average age at 49.47 ± 22.69 years. As for gender distributions, the ratio of male- to-female patients was 1:1.36 (242:328). Geographic analysis showed that 377 patients (66.1%) were in Hanjiang District while 188 patients (33.0%) were in Guangling District. Clinical diagnosis showed that 175 people (30.7%) had mild symptoms, 385 people were in moderate conditions (67.5%), and 10 people were in severe situations (1.8%). Significant age differences were found among the three groups (P < 0.001). However, no significant difference was identified in terms of gender ratio (P > 0.05). Based on the transmission chain formed by 6 generations of infected persons with a clear transmission relationship, the age showed a gradually decreasing trend, while the median time of diagnosis in 2 adjacent generations was 3 days. In addition, the estimated basic reproduction number R0 of the Delta variant was 3.3651 by the classical Susceptible, Infectious, and/or Recovered (SIR) model.

Conclusion: The Delta variant of SARS-CoV-2 was highly infectious and has obvious clustering characteristics during the Yangzhou outbreak in China.

Introduction

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been widely spread worldwide since the end of 2019 (Poon and Peiris, 2020), resulting in a serious impact on human health and global economy. As of now, according to the Coronavirus Resource Center at Johns Hopkins University & Medicine,1 the number of confirmed COVID-19 patients worldwide has exceeded 488 million and the death toll has exceeded 6.14 million, and the administration of vaccine doses have exceeded 10.88 billion (World Health Organization, 2020). With the accelerating mutation rates of the SARS-CoV-2 virus, new variant strains, such as α, β, γ, δ, and ε, are constantly emerging (Boehm et al., 2021; Giovanetti et al., 2021), not even mentioning the recently emerged highly contagious Omicron strain. The spread and pathogenicity of these mutant strains in the population showed an increasing trend (Janik et al., 2021; Plante et al., 2021; Yi and Wenhong, 2021), leading to the continued spread of COVID-19 worldwide. Therefore, the current international epidemic situation is still complex and severe. As for the worldwide model of COVID-19 prevention and control due to the low infection and death rates, the experience from China has high values of practical guidance. With the efforts of medical staff to actively participate in epidemic control, the epidemic situation of COVID-19 has been effectively controlled. However, due to the uncertainties of SARS-CoV-2 transmission, epidemic still occurs sporadically in local areas. In the face of the increasingly severe epidemic situation abroad and the great import pressure of confirmed cases from foreign countries, there have been short-term and small-scale COVID-19 outbreaks in China recently. Since 28 July 2021, the outbreak of COVID-19 in Yangzhou has been caused by related cases in the Nanjing Lukou International Airport. After nearly a month of hard work, the epidemic was effectively controlled. According to the epidemiological data reported by the Yangzhou Health Commission,2 the situation of the epidemic situation was preliminarily analyzed and reported in this study.

Materials and Methods

Data Collection

All the data Son COVID-19 in Yangzhou came from the epidemic report issued on the public official website of the Yangzhou Commission of Health and were released by the Yangzhou Municipal Government’s Press from 28 July to 26 August 2021, all of which were deidentified and available publicly. Information, such as personnel number, age, sex, address, diagnosis, date of diagnosis, and close contacts of each confirmed case, was collected from the public website. Therefore, no informed consent forms and ethics approval were needed for this study.

Analysis of Epidemic Characteristics

All the COVID-19 cases were collected and constructed into a formatted dataset. A descriptive epidemiological method was adopted to analyze the time, place, and population characteristics of COVID-19 in Yangzhou from 28 July to 26 August 2021.

Preliminary Discussion on Factors Affecting Disease Classification in COVID-19

There were three types of infections for the disease, that is, mild, common, and severe, based on the Diagnosis and Treatment Protocol for the COVID-19 patients jointly released by the National Health Commission of the People’s Republic of China and the National Administration of Traditional Chinese Medicine (Trial Version Eight; National Health Commission, 2022). In this study, all the patients were divided into three groups according to disease types that was confirmed by the Yangzhou Municipal Government via their daily-released public report, which were then compared through differences in genders, ages, and addresses.

Analysis of the Spread of COVID-19 in the Population

We sorted out the transmission chains of all confirmed cases during Yangzhou Outbreak according to the information in the epidemic notification updated daily by the Yangzhou Municipal Government. The confirmed cases from Jiangning District in Nanjing (the Capital City of Jiangsu Province that was adjacent to Yangzhou) were designated as the 0th generation of infected persons, while the confirmed cases in close contact with the 0th generation of infected persons were recorded as the 1st generation of infected persons, and so on and so forth. The number and basic information of infected persons in each generation were enumerated and recorded, leading to the formation of a complete and clear transmission chain.

Mathematical Model of the Spread of COVID-19

The classic Susceptible, Infectious, and/or Removed (SIR) epidemic model for infectious diseases proposed by Kermack and McKendrick (1927) was used to mathematically model the current round of COVID-19 transmission chain in Yangzhou in this study. In the SIR model, S, I, and R correspond to the numbers of susceptible, infected, and removed people, respectively. The rules for the dynamic changes in the numbers of the three groups of people over time could be expressed by the following ordinary differential Equations 1–3:

dSdt=-βSIN     (1)
dIdt=βSIN-γI    (2)
dRdt=γI      (3)

where N indicates the total number of people, and β is the infection rate of susceptible people in contact with infected persons, and γ is the average recovery rate of the infected population, which is a fixed value that depends on the average duration of infection.

Then, we made determinations of the main parameters in the equations. The initial values of S, I, and R were set to 1, N - 1, and 0, respectively, where N was the total population of Yangzhou City. γ was the recovery rate. The recovery period of the COVID-19 epidemic was about 30 days, so γ was set to be 1/30. To facilitate the identifications of parameters, we then made a simplification of the above SIR model. Since the number of patients in the early stage of transmission was small, it was approximated that all people were susceptible people, that is, S≈N. Thus, Equation 2 was re-formulated as Equation 4 here:

dIdt=(β-γ)I    (4)

Through Equation 4, it was convenient to know that the general solution of the differential equation was:

I(t)=Ce(β-γ)t   (5)

where C was a constant. C was equal to 1 since I(t = 0) = 1. Thus, Equation 5 could be written as:

I(t)=e(β-γ)t    (6)

Therefore, the following parameter identification problem could be constructed:

Decision variable: infection rate β

Objective function: mintT(e(β-γ)t-I^(t))2  (7)

where I^ was the actual number of patients (real-world data) and t was the time set in a day. Our model could be hypothesized as follows: a sick person was in close contact with 5 people every day and the recovery rate γ = 1/30 and N≈S in the early stage of the epidemic. The infection rate of COVID-19 could be obtained by solving the aforementioned optimization problem.

The infection rate could be written as β = nContact × infecProb, where nContact was the number of uninfected people that infected people came into contact with each day, and infecProb was the infection probability. The basic reproduction number of COVID-19 could be estimated based on the following Equation 8:

R0=βγ   (8)

Statistical Analysis

The software SPSS 20.0 was used for the statistical analysis. x¯ ± s was applied to describe the measurement data, where x¯ indicated the mean and s indicated standard variance. Frequency and composition were used to compare the counting data. In the analysis of influencing factors of disease typing, the non-parametric test was applied if the measurement data did not meet the homogeneity of variance, and count data were tested using the χ2 test or Fisher’s test.

Results

General Information

Yangzhou is located in the middle of Jiangsu Province, and its southwest border is adjacent to Nanjing as shown in Figure 1. From 28 July to 26 August 2021, Yangzhou had reported 570 confirmed cases, including 242 men (42.5%) and 328 women (57.5%) with an average age of 49.47 ± 22.69 years. After grouping by age, there were 77 (13.51%) within 0–18 years old, 122 (21.40%) within 19–40 years old, 145 (25.44%) in 41–60 years old, and 226 (39.65%) over 61 years old, of which the elderly over 61 years old accounted for the most. The geographic distribution of confirmed cases in Yangzhou based on their addresses was as following: 188 people (33.0%) in Guangling district, 377 people (66.1%) in Hanjiang District, and 5 people (0.9%) in Jiangdu district, of which the number of confirmed cases in Hanjiang District accounts for more than half of the total confirmed cases. According to the COVID-19 guideline (National Health Commission, 2022), the confirmed cases consisted of 175 (30.7%) in mild type, 385 (67.5%) in common type, and 10 (1.8%) in severe type. Thus, the common type had the largest ratio of confirmed cases.

FIGURE 1
www.frontiersin.org

Figure 1. Schematic illustration of the Yangzhou City geography and the corresponding distribution of confirmed cases in different districts of Yangzhou City. A total of six districts in Yangzhou City were present with confirmed COVID-19 cases, which were Baoying (N = 0), Gaoyou (N = 0), Yizheng (N = 0), Hanjiang (N = 377), Guangling (N = 188), and Jiangdu (N = 5).

The time distribution of the number of confirmed patients per day was further investigated, which was sorted according to the date of diagnosis in the daily report by the Yangzhou Municipal Government. In particular, the time of diagnosis was mainly from 28 July to 26 August, with the peak period from 1 to 14 August. The number of confirmed patients showed an obvious upward trend, peaked, and then fluctuated down. The largest daily confirmed number appeared in 5 August. In terms of age composition for the confirmed cases per day, the proportion of people over 61 years old group was significantly higher than that in other age groups in the early stage of the epidemic (before 8 August 2021), then gradually decreased until the epidemic was over. The changing pattern of the COVID-19 patients was visualized in details in Figure 2.

FIGURE 2
www.frontiersin.org

Figure 2. Quantitative visualization of the daily diagnostic number of COVID-19 in Yangzhou, China. The compositions of confirmed cases in different age groups were characterized by cumulative bars in different colors. Green bar: < 19 years old. Blue bar: between 19 and 40 years old. Yellow bar: between 41 and 60 years old. Red bar: > 60 years old.

Preliminary Study on Influential Factors of COVID-19 Disease Classification

The differences in age distribution, gender distribution, and regional distribution in the three groups of the mild type, common type, and severe type of confirmed the COVID-19 cases were analyzed by statistical methods. The results were shown in Table 1. Since the age data of the three groups did not meet the homogeneity of variance, the non-parametric test was used for the analysis of the age difference. The average age rank of the mild group was smaller, while the average age rank of the severe group was larger. The results showed that the age of the mild group was lower while the age of the severe group was higher (H = 3.177,P < 0.001). There was no significant difference in gender composition among the three groups by the chi-squared test (χ2 = 3.177,P = 0.204). The statistical results showed that the gender composition of patients with mild, common, and severe COVID-19 was similar in the three groups. In terms of regional distribution, the number of patients in Jiangdu district was significantly less than that in Hanjiang District and Guangling district. Statistical analysis by the Fisher’s exact probability method showed that the composition of the three groups was different (P value = 0.029). Therefore, of all the patients in Yangzhou, common and severe cases were mainly distributed in the Hanjiang District.

TABLE 1
www.frontiersin.org

Table 1. Differences in age, gender, and regional distribution of the confirmed COVID-19 patients with different disease types.

Analysis of the Spread of COVID-19 in Population

According to the reported contact relationship in the epidemic notification, a complete and clear COVID-19 transmission chain was sorted out, with a total of 198 infected patients in 6 generations. The number of confirmed patients, average age, gender composition, address distribution, disease classification, and median date of diagnosis of each generation were shown in Table 2. Among the 6 generations of confirmed patients with clear infectious relationships, the age tended to decrease gradually. The median diagnosis time between the adjacent 2 generations was around 1–5 days, and the median time was 3 days.

TABLE 2
www.frontiersin.org

Table 2. Basic information of communication chain formed by six generations of confirmed patients.

The Mathematical Model of COVID-19 Communication

Through SIR model, we calculated the identification result as infecProb = 0.02243 and infection rate as β = 0.11217. The basic reproduction number of COVID-19 was estimated to be R0 = 3.3651. The results showed that a person infected with COVID-19 would transmit the disease to 3.37 susceptible persons on average during the Yangzhou epidemic. Figure 3 showed the numerical change curve of SIR model for the Yangzhou epidemic.

FIGURE 3
www.frontiersin.org

Figure 3. Simulation of the numerical change curve through SIR model for the Yangzhou epidemic. Yellow line: number of infected persons. Green line: number of recovery persons.

Discussion

The first confirmed COVID-19 case was reported in Yangzhou on 28 July 2021 and the epidemic was effectively controlled on 26 August 2021. Thus, the newly emerging COVID-19 outbreak in Yangzhou lasted for less than a month before completely and timely control of the situation. Center for Disease Control and Prevention of Jiangsu province confirmed that the virus strain circulating in Yangzhou was Delta B.1.617.2 variant (Yangzhou Municipal People’s Government, 2021; Hu et al., 2022). SARS-CoV-2 of Delta type initially emerged in India in October 2020 (Cascella et al., 2022) and was one of the five variants of concerns (VOCs) by the WHO. So far, the Delta strain has caused epidemics in many countries and regions around the world. Mutations in the Delta-type virus strain can lead to an increased affinity between the spinous process protein and the ACE 2 receptor, thereby enhancing viral adhesion and subsequent entry into host cells (Cascella et al., 2022). COVID-19 caused by this strain is characterized by high viral load, rapid replication in vivo, rapid transmission, strong infectivity, and high virulence, which leads to shortened incubation period of the disease (Du et al., 2021; Hu et al., 2022), certain immune escape ability of the virus (Mlcochova et al., 2021), and higher hospitalization rate of the infected (Callaway, 2021). As a result, the main urban area of Yangzhou broke out with COVID-19 in a short period of time.

Nevertheless, the clinical symptoms of patients infected with the Delta variant strain appeared to be less severe than those of the wild-type strain. Hu et al. compared the inpatients during the epidemic in Yangzhou with those during the epidemic in Wuhan in 2020, and found no difference in gender, age, and the prevalence of underlying diseases, such as hypertension, diabetes, and cardiovascular disease, between the two groups (Hu et al., 2022). The study found that patients infected with the Delta variant SARS-CoV-2 had a significantly lower frequency of major clinical symptoms, such as cough and fever than those infected with the wild-type strain. However, a new symptom of sore throat was found in patients infected with the Delta variant (Hu et al., 2022). Epidemiological survey information showed that among the confirmed cases of the epidemic in Yangzhou, there were more elderly people older than 61 years, and the 10 severe patients were all over 70 years. In the early stage of the epidemic, the characteristics of site aggregation infection were obvious. There were a large number of elderly patients who were infected and had not formed effective immune protection, resulting in some severe cases among infected people. From April to July, the Center for Disease Control and Prevention (CDC) conducted an epidemiological survey of more than 600,000 COVID-19 cases in the United States mainland, the result of which showed that 569,142 cases (92%) had not completed all vaccination procedures and 46,312 cases (8%) had completed all vaccination procedures; among those hospitalized with COVID-1,9 34,972 (92%) unvaccinated and 2,976 (8%) vaccinated were completed; among people who died from COVID-19, 6,132 (91%) were unvaccinated and 616 (9%) were vaccinated (Scobie et al., 2021). As a result, the risk of contracting COVID-19 was about 10 times higher for people who had not completed the full vaccination process. Therefore, vaccination was an effective means of preventing COVID-19 infection and reducing hospitalizations and mortality.

Previous studies had shown that the median incubation period of COVID-19 was about 5.1 days (95% CI, 4.5–5.8 days; Lauer et al., 2020), and transmission could occur during the incubation period (Liu et al., 2020; Yu et al., 2020). Most patients developed symptoms within 11.5 days after infection (Lauer et al., 2020). The difference was that the mean incubation period of the Delta strain of COVID-19 was only 4.4 days (Zhang et al., 2021), and the mean interval between generations was 2.9 days. By comparing the median diagnosis time of 6 generations of infected persons in Yangzhou, it was found that the median diagnosis time of 2 adjacent generations was only 3 days. The passage interval of the disease was significantly shortened and the virus was spread much faster. In the terms of human transmission, the epidemic was mainly among the elderly at the beginning and gradually spread to the general population. As can be seen from Table 1, in the early stage of the epidemic, the daily number of confirmed cases and the relative proportion of elderly people aged over 61 were significantly higher than those of other age groups, and gradually decreased after 8 August. For other age groups, the daily number of confirmed cases increased significantly after 4 August, and the overall number also showed a trend of first increment and then decrement. In addition, there was an overall decrease in the age of each generation in the transmission chain consisting of six generations of the confirmed patients with clear contacts.

The basic reproduction number is an important indicator to measure the infectiousness of an infectious disease. Using the SIR transmission model of infectious diseases, combined with the data reported in the Yangzhou outbreak, the R0 of Delta variant of SARS-CoV-2 in this outbreak was calculated as 3.3651. The results indicated that one person infected with COVID-19 in the Yangzhou outbreak would transmit the disease to an average of 3.37 susceptible persons. Wang et al. (2020) evaluated the basic reproductive number of COVID-19 in China and obtained R0 was equal to 3.49 with 95% CI at 3.42–3.58. Yu et al. (2020) analyzed cluster outbreaks caused by Delta mutant strains in Guangdong Province and calculated that R0 was about 3.2, significantly higher than that of wild strains. Liu et al. (2021), based on model studies, found that the R0 of the Delta variant strain was about 6 in the absence of ideal transmission of any intervention. A study from the United Kingdom on the transmissibility of the Delta mutant strain estimated R0 to be about 7 (Burki, 2021). These results suggest that the transmissibility of the Delta variant is significantly higher than that of the Alpha variant.

Until now, China has experienced several local, short, small-scale COVID-19 outbreaks. However, with the intervention of the government’s effective epidemic prevention policy, the big data method has been used to quickly lock and isolate the infected and close contacts. The government also carried out large-scale nucleic acid screenings as soon and as often as possible (Li et al., 2021), strengthened the control of epidemic-affected communities, and enhanced public health measures at the community level (Li and Gao, 2020). Early detection, early reporting, early isolation, and early treatment of infected persons also contributed to the quickly control of and shorten the duration of the epidemic. As a result, the epidemic in all regions of China has been brought under control quickly and efficiently, which made the infected cases rarely spread to other areas. However, there were also some limitations to the study. At first, the data were all from the epidemic notification issued by the Health Commission of Yangzhou and the Yangzhou Municipal Government, which could only represent the infected population in Yangzhou. Second, the amount of collected information was relatively small, so the research on diseases was not comprehensive and detailed enough. Taking disease typing as an example, the ten severe cases sorted out in this study were diagnosed by the doctors initially without considering the development and outcome of later diseases. Thus, a part of the confirmed patients who turned into severe cases in the treatment process was not included, which might be inconsistent with the total number of severe patients sorted out after the epidemic. Therefore, to increase the accuracy and reliability of research results, subsequent studies were definitely needed to include data from multiple regions for an integrative analysis.

Conclusion

In this study, we thoroughly sorted out the transmission chains of all confirmed cases in Yangzhou, which was currently the only complete epidemiological analysis of the COVID-19 outbreak in Yangzhou. The Delta variant of SARS-CoV-2 in the Yangzhou outbreak was also highly contagious as expected. There were a large number of COVID-19 infected patients in the age group greater than 61 years old, and the main type of the disease was classified as common with a certain number of severe cases. The interval time between the diagnosis of two generations of patients was significantly shortened, and the spreading rate of the virus was increased. Therefore, the experience of the epidemic situation in Yangzhou was that, by executing scientific and accurate prevention and control strategies, carrying out large-scale nucleic acid screening and community control as soon as possible, and by isolating and treating infected persons, can the epidemic situation be quickly contained with less casualties at a municipal level, which could also provide references for better control and prevention of the COVID-19 outbreak in other regions.

Data Availability Statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Ethics Statement

All the data were deidentified and publicly accessible. There is no need to require ethical approval for the study.

Author Contributions

Y-DZ, LW, and J-QX contributed to the design of the research. F-MC and Y-DZ collected and sorted out the raw data. R-YW and J-QX carried out the statistical analysis of the data. LH and LS constructed the SIR model. Y-DZ and DC completed the first draft of the article. All authors critically revised and approved the submitted version.

Funding

Yudong Zhang appreciated the financial support from the University Philosophy and Social Science Research Foundation of Jiangsu Education Department (2020SJA1064) and the research start fund for outstanding talents of the Xuzhou Medical University (D2017018). LW is grateful of the financial support by the Young Science and Technology Innovation Team of Xuzhou Medical University (TD202001). We also thank the financial support of the Collaboration and Innovation Project of Xuzhou Medical University (XYRHCX2021018 and XYRHCX2021008).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

We greatly appreciate the reviewers whose comments and suggestions helped improve and clarify this article.

Footnotes

  1. ^ https://coronavirus.jhu.edu/map.html
  2. ^ http://wjw.yangzhou.gov.cn/yzwshjh/ywkd/wjw_list.shtml

References

Boehm, E., Kronig, I., Neher, R. A., Eckerle, I., Vetter, P., Kaiser, L., et al. (2021). Novel SARS-CoV-2 variants: the pandemics within the pandemic. Clin. Microbiol. Infect. 27, 1109–1117. doi: 10.1016/j.cmi.2021.05.022

CrossRef Full Text | Google Scholar

Burki, T. K. (2021). Lifting of COVID-19 restrictions in the UK and the Delta variant. Lancet Respir. Med. 9:e85. doi: 10.1016/S2213-2600(21)00328-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Callaway, E. (2021). Delta coronavirus variant: scientists brace for impact. Nature 595, 17–18. doi: 10.1038/d41586-021-01696-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Cascella, M., Rajnik, M., Aleem, A., Dulebohn, S. C., and Di Napoli, R. (2022). Features, Evaluation, and Treatment of Coronavirus (COVID-19). Treasure Island, FL: StatPearls Publishing.

Google Scholar

Du, M., Liu, M., and Liu, J. (2021). Progress in research of epidemiologic feature and control of SARS-CoV-2 Delta variant. Zhonghua Liu Xing Bing Xue Za Zhi 42, 1774–1779. doi: 10.3760/cma.j.cn112338-20210808-00619

CrossRef Full Text | Google Scholar

Giovanetti, M., Benedetti, F., Campisi, G., Ciccozzi, A., Fabris, S., Ceccarelli, G., et al. (2021). Evolution patterns of SARS-CoV-2: snapshot on its genome variants. Biochem. Biophys. Res. Commun. 538, 88–91. doi: 10.1016/j.bbrc.2020.10.102

CrossRef Full Text | Google Scholar

Hu, Z., Huang, X., Zhang, J., Fu, S., Ding, D., and Tao, Z. (2022). Differences in Clinical Characteristics Between Delta Variant and Wild-Type SARS-CoV-2 Infected Patients. Front. Med. 8:792135. doi: 10.3389/fmed.2021.792135

CrossRef Full Text | Google Scholar

Janik, E., Niemcewicz, M., Podogrocki, M., Majsterek, I., and Bijak, M. (2021). The Emerging Concern and Interest SARS-CoV-2 Variants. Pathogens 10:633. doi: 10.3390/pathogens10060633

CrossRef Full Text | Google Scholar

Kermack, W., and McKendrick, A. (1927). A contribution to the mathematical theory of epidemics. Proc. R. Soc. Lond. A 115, 700–721. doi: 10.1007/s11538-013-9866-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., et al. (2020). The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: estimation and Application. Ann. Intern Med. 172, 577–582. doi: 10.7326/M20-0504

CrossRef Full Text | Google Scholar

Li, Z., and Gao, G. F. (2020). Strengthening public health at the community-level in China. Lancet Public Health 5, e629–e630. doi: 10.1016/S2468-2667(20)30266-8

CrossRef Full Text | Google Scholar

Li, Z., Liu, F., Cui, J., Peng, Z., Chang, Z., Lai, S., et al. (2021). Comprehensive large-scale nucleic acid-testing strategies support China’s sustained containment of COVID-19. Nat. Med. 27, 740–742. doi: 10.1038/s41591-021-01308-7

CrossRef Full Text | Google Scholar

Liu, H., Zhang, J., Cai, J., Deng, X., Peng, C., Chen, X., et al. (2021). Herd immunity induced by COVID-19 vaccination programs and suppression of epidemics caused by the SARS-CoV-2 Delta variant in China. medRxiv [Preprint]. doi: 10.1101/2021.07.23.21261013

CrossRef Full Text | Google Scholar

Liu, Y. C., Liao, C. H., Chang, C. F., Chou, C. C., and Lin, Y. R. A. (2020). Locally Transmitted Case of SARS-CoV-2 Infection in Taiwan. N. Engl. J. Med. 382, 1070–1072. doi: 10.1056/NEJMc2001573

CrossRef Full Text | Google Scholar

Mlcochova, P., Kemp, S. A., Dhar, M. S., Papa, G., Meng, B., Datir, R., et al. (2021). SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 599, 114–119. doi: 10.1038/s41586-021-03944-y

PubMed Abstract | CrossRef Full Text | Google Scholar

National Health Commission (2022). Diagnosis and Treatment Protocol for COVID-19 Patients (Trial Version 8). Available online at: https://covid19.alliancebrh.com/covid19en/c100036/202008/12b9b42813a9475 5bbf442008fe86f63/files/b0ae9b6c1d9a47bf81d7dc1f5e7ddda5.pdf

Google Scholar

Plante, J. A., Mitchell, B. M., Plante, K. S., Debbink, K., Weaver, S. C., and Menachery, V. D. (2021). The variant gambit: COVID-19’s next move. Cell Host Microbe 29, 508–515. doi: 10.1016/j.chom.2021.02.020

CrossRef Full Text | Google Scholar

Poon, L. L. M., and Peiris, M. (2020). Emergence of a novel human coronavirus threatening human health. Nat. Med. 26, 317–319. doi: 10.1038/s41591-020-0796-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Scobie, H. M., Johnson, A. G., Suthar, A. B., Severson, R., Alden, N. B., Balter, S., et al. (2021). Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status - 13 U.S. Jurisdictions, April 4-July 17, 2021. MMWR Morb. Mortal Wkly. Rep. 70, 1284–1290. doi: 10.15585/mmwr.mm7037e1

CrossRef Full Text | Google Scholar

Wang, Y., You, X. Y., Wang, Y. J., Peng, L. P., Du, Z. C., Gilmour, S., et al. (2020). Estimating the basic reproduction number of COVID-19 in Wuhan, China. Zhonghua Liu Xing Bing Xue Za Zhi 41, 476–479. doi: 10.3760/cma.j.cn112338-20200210-00086

CrossRef Full Text | Google Scholar

World Health Organization (2020). WHO Coronavirus (COVID-19) Dashboard [EB/OL]. Available online at: https://covid19.who.int. (accessed on Jan 15, 2022).

Google Scholar

Yangzhou Municipal People’s Government (2021). Yangzhou City Epidemic Prevention and Control Press Conference (Session 2). Available online at: http://www.yangzhou.gov.cn/yzszxxgk/zfb/202108/f3e1816f25444f129030b042476ab1a4.shtml (accessed December 31, 2021).

Google Scholar

Yi, Z., and Wenhong, Z. (2021). novel coronavirus variants: current status, trends and countermeasures. CHIN. J. Infect. Dis. 39, 321–324. doi: 10.3760/cma.j.cn311365-20210416-00136

CrossRef Full Text | Google Scholar

Yu, P., Zhu, J., Zhang, Z., and Han, Y. A. (2020). Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period. J. Infect. Dis. 221, 1757–1761. doi: 10.1093/infdis/jiaa077

CrossRef Full Text | Google Scholar

Zhang, M., Xiao, J., Deng, A., Zhang, Y., Zhuang, Y., Hu, T., et al. (2021). Transmission Dynamics of an Outbreak of the COVID-19 Delta Variant B.1.617.2 - Guangdong Province, China, May-June 2021. CHIN. CDC Wkly. 3, 584–586. doi: 10.46234/ccdcw2021.148

CrossRef Full Text | Google Scholar

Keywords: COVID-19, SARS-CoV-2, epidemiology, outbreak, basic reproduction number

Citation: Zhang Y-D, Chen D, Hu L, Shen L, Wu R-Y, Cao F-M, Xu J-Q and Wang L (2022) Epidemiological Characteristics of COVID-19 Outbreak in Yangzhou, China, 2021. Front. Microbiol. 13:865963. doi: 10.3389/fmicb.2022.865963

Received: 30 January 2022; Accepted: 04 April 2022;
Published: 06 May 2022.

Edited by:

Pragya Dhruv Yadav, ICMR-National Institute of Virology, India

Reviewed by:

Christian Albert Devaux, Centre National de la Recherche Scientifique (CNRS), France
Wei Wang, Edith Cowan University, Australia

Copyright © 2022 Zhang, Chen, Hu, Shen, Wu, Cao, Xu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Liang Wang, healthscience@foxmail.com

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.